Iradimed (IRMD) Non-Current Deffered Revenue (2013 - 2026)
Iradimed (IRMD) posted quarterly Non-Current Deffered Revenue of $4.1 million for Q2 2026, up 21.95% year-over-year from $3.3 million in Q2 2025, and up 8.14% on a QoQ basis from $3.8 million in Q1 2026.
Iradimed (IRMD) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends
Iradimed has reported Non-Current Deffered Revenue for 14 years, with the latest figure at $4.1 million in Q2 2026.
- Non-Current Deffered Revenue for Q2 2026 came in at $4.1 million, up 21.95% year-over-year; the trailing twelve-month figure through Jun 2026 was $4.1 million (up 21.95% YoY), and the FY2025 annual result was $4.0 million, up 32.91% from the prior year.
- Non-Current Deffered Revenue advanced to $4.1 million in Q2 2026, from $3.8 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $4.1 million in Q2 2026 and troughed at $1.4 million in Q4 2022.
- A 5-year average of $2.9 million and a median of $2.9 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- The widest annual swing landed in 2022, when Non-Current Deffered Revenue retreated 29.82%; it then soared 103.14% in 2023.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $1.4 million in 2022, then soared by 103.14% to $2.8 million in 2023, then rose by 7.14% to $3.0 million in 2024, then soared by 32.91% to $4.0 million in 2025, then rose by 2.14% to $4.1 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $4.1 million in Q2 2026, $3.8 million in Q1 2026, and $4.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | 4.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.06 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 2.76 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 3.23 Mn |
| Jun 30, 2023 | 3.01 Mn |
| Mar 31, 2023 | 2.59 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 2.18 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 1.68 Mn |
| Sep 30, 2021 | 1.91 Mn |